Company / Income Tax
AVADEL PHARMACEUTICALS PLC Income Tax History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
-$247.0K
FY2024
5-year range
-$15.8M / $26.0M
FY2020-FY2024
Trend
+50.7%
vs FY2023
Sector context
#176 of 204
Health Care
What the data says
AVADEL PHARMACEUTICALS PLC's income tax of -$247,000 is lower than 86% of companies in the Health Care sector (FY2024). Income Tax has fluctuated over the past 10 years, ranging from -$18M in FY2018 to $36M in FY2015.
Based on SEC 10-K filings.
-$247,000 in FY2024.
Improved from $26M to -$247,000 over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 14% in Health CareTop 14% of 204This company -$247.0K Sector average $118.7M
▼
-100.2% below sector average
Key checks
Key Insights
- In FY2024, income tax increased 50.7% year-over-year.
- Ranks #176 out of 204 companies in the Health Care sector.
- Peak income tax was recorded in FY2015.
- Lowest income tax in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -28.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$247.0K | +50.7% |
| FY2023 | -$501.0K | -101.9% |
| FY2022 | $26.0M | +264.5% |
| FY2021 | -$15.8M | -30.6% |
| FY2020 | -$12.1M | -126.1% |
| FY2019 | -$5.4M | +70.1% |
| FY2018 | -$17.9M | -173.4% |
| FY2017 | $24.4M | -22.7% |
| FY2016 | $31.6M | -12.1% |
| FY2015 | $35.9M | +5675.6% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026